Not a Lexis Advance subscriber? Try it out for free.


Mealey's IP/Tech - Vaccine Stabilization Patent Could Be Obvious, Federal Circuit Says

WASHINGTON, D.C. - In a Nov. 26 ruling, the Federal Circuit U.S. Court of Appeals vacated and remanded findings by the Patent Trial and Appeal Board that one claim of a Wyeth LLC patent directed to formulations for stabilizing polysaccharide-protein conjugate vaccines is not obvious (Merck Sharp & Dohme Corp. v. Wyeth LLC, No. 18-2133, Fed. Cir., 2019 U.S. App. LEXIS 35352).
Find full version on lexis Advance®